CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

Clinical trial NCT07207811 · RECRUITING

Trial details

NCT number: NCT07207811
Sponsor: Novo Nordisk A/S
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Transthyretin Amyloid Cardiomyopathy (ATTR CM)

Start date: 2025-10-02
Primary completion: 2029-06-29
Enrollment: 1280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.